Compass Pathways plc [CMPS] vs Pediatrix Medical [MD] Detailed Stock Comparison

Compass Pathways plc

NASDAQ
Loading...

Pediatrix Medical Group, Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Compass Pathways plc wins in 1 metrics, Pediatrix Medical Group, Inc. wins in 15 metrics, with 0 ties. Pediatrix Medical Group, Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Compass Pathways plc Pediatrix Medical Group, Inc. Better
P/E Ratio (TTM) -3.11 11.88 Pediatrix Medical Group, Inc.
Price-to-Book Ratio -16.96 2.16 Pediatrix Medical Group, Inc.
Debt-to-Equity Ratio -0.66 73.29 Pediatrix Medical Group, Inc.
PEG Ratio -0.05 9.90 Pediatrix Medical Group, Inc.
EV/EBITDA -6.40 7.92 Pediatrix Medical Group, Inc.
Profit Margin (TTM) 0.00% 8.64% Pediatrix Medical Group, Inc.
Operating Margin (TTM) 0.00% 11.07% Pediatrix Medical Group, Inc.
EBITDA Margin (TTM) N/A 11.07% N/A
Return on Equity -565.28% 20.28% Pediatrix Medical Group, Inc.
Return on Assets (TTM) -51.68% 6.57% Pediatrix Medical Group, Inc.
Free Cash Flow (TTM) $-157.24M $252.63M Pediatrix Medical Group, Inc.
1-Year Return 175.17% 73.57% Compass Pathways plc
Price-to-Sales Ratio (TTM) N/A 1.00 N/A
Enterprise Value $1.12B $2.00B Pediatrix Medical Group, Inc.
EV/Revenue Ratio N/A 1.05 N/A
Gross Profit Margin (TTM) N/A 25.51% N/A
Revenue per Share (TTM) $0 $23 Pediatrix Medical Group, Inc.
Earnings per Share (Diluted) $-3.08 $1.94 Pediatrix Medical Group, Inc.
Beta (Stock Volatility) 2.02 0.72 Pediatrix Medical Group, Inc.
Short % of Float 8.27% 6.00% Pediatrix Medical Group, Inc.

Compass Pathways plc vs Pediatrix Medical Group, Inc. Stock Performance Analysis

Loading Price Chart...

CMPS
MD

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Compass Pathways plc-2.40%0.51%13.69%86.85%78.91%80.00%
Pediatrix Medical Group, Inc.0.29%8.46%8.36%25.04%7.40%14.47%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Compass Pathways plc175.17%57.09%-66.76%-58.34%-58.34%-58.34%
Pediatrix Medical Group, Inc.73.57%75.20%-20.69%-64.71%-31.34%9.12%

Performance & Financial Health Analysis: Compass Pathways plc vs Pediatrix Medical Group, Inc.

MetricCMPSMD
Market Information
Market Cap i$1.29B$1.91B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i8,773,810510,889
90 Day Avg. Volume i4,226,373755,756
Last Close$11.79$24.37
52 Week Range$2.25 - $14.76$11.84 - $24.99
% from 52W High-20.12%-2.48%
All-Time High$61.69 (Dec 14, 2020)$86.09 (Aug 17, 2015)
% from All-Time High-80.89%-71.69%
Growth Metrics
Quarterly Revenue GrowthN/A-0.02%
Quarterly Earnings GrowthN/A0.11%
Financial Health
Profit Margin (TTM) i0.00%0.09%
Operating Margin (TTM) i0.00%0.11%
Return on Equity (TTM) i-5.65%0.20%
Debt to Equity (MRQ) i-0.6673.29
Cash & Liquidity
Book Value per Share (MRQ)$-0.55$10.68
Cash per Share (MRQ)$1.16$6.16
Operating Cash Flow (TTM) i$-157,240,000$271.09M
Levered Free Cash Flow (TTM) i$97.14M$190.33M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Compass Pathways plc vs Pediatrix Medical Group, Inc.

MetricCMPS (Apr 26, 2026)MD (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-3.1111.88
Forward P/E i-8.029.90
PEG Ratio i-0.059.90
Price to Sales (TTM) iN/A1.00
Price to Book (MRQ) i-16.962.16
Market Capitalization
Market Capitalization i$1.29B$1.91B
Enterprise Value i$1.12B$2.00B
Enterprise Value Metrics
Enterprise to Revenue iN/A1.05
Enterprise to EBITDA i-6.407.92
Risk & Other Metrics
Beta i2.020.72
Book Value per Share (MRQ) i$-0.55$10.68

Financial Statements Comparison: Compass Pathways plc vs Pediatrix Medical Group, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCMPS (2025)MD (2025)
Revenue/Sales i01.91B
Cost of Goods Sold iN/A1.42B
COGS % of Revenue i-74.2%
Gross Profit iN/A493.70M
Gross Margin i-25.8%
Research & Development i118.44MN/A
Operating Income (EBIT) i-175.29M231.09M
Operating Margin i-12.1%
EBITDA i-166.51M256.55M
EBITDA Margin i-13.4%
Pre-Tax Income i-290.34M216.43M
Pre-Tax Income % of Revenue i-11.3%
Income Tax i-2.47M51.04M
Income Tax % of Revenue i-2.7%
Net Income (Profit) i-287.86M165.39M
Profit Margin i-8.6%

Balance Sheet & Liquidity Metrics

MetricCMPS (2025)MD (2025)
Cash & Equivalents i149.61M375.24M
Total Current Assets i191.49M763.51M
Total Current Assets % of Revenue i-39.9%
Total Current Liabilities i247.80M458.91M
Total Current Liabilities % of Revenue i-24.0%
Long-Term Debt i15.40M596.22M
Long-Term Debt % of Revenue i-31.2%
Total Shareholders Equity i-52.85M865.85M
Retained Earnings i-822.59M-83.15M
Retained Earnings % of Revenue i--4.3%
Property, Plant & Equipment i3.42M195.53M

Cash Flow Statement Comparison

MetricCMPS (2025)MD (2025)
Operating Cash Flow i-264.80M270.23M
Operating Cash Flow % of Revenue i-14.1%
Capital Expenditures iN/A-18.46M
Free Cash Flow i-157.24M252.63M
FCF Margin i-13.2%
Debt Repayment iN/A-20.75M
Common Stock Repurchase iN/A-86.68M

Short Interest & Institutional Ownership Analysis

MetricCMPSMD
Shares Short i11.01M3.53M
Short Ratio i5.653.77
Short % of Float i8.27%6.00%
Shares Outstanding i96.09M82.98M
Float Shares i103.35M79.95M
% Held by Insiders i8.04%2.31%
% Held by Institutions i44.76%106.63%
% Held by Public i47.20%-8.94%

Dividend Analysis & Yield Comparison: Compass Pathways plc vs Pediatrix Medical Group, Inc.

MetricCMPSMD
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A